Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. Blanco JG, Sun CL, Landier W, Chen L, Esparza-Duran D, Leisenring W, Mays A, Friedman DL, Ginsberg JP, Hudson MM, Neglia JP, Oeffinger KC, Ritchey AK, Villaluna D, Relling MV, Bhatia S (2012) J Clin Oncol 30: 1415-21 Estimated rate of prostacyclin secretion into the circulation of normal man. FitzGerald GA, Brash AR, Falardeau P, Oates JA (1981) J Clin Invest 68: 1272-6 Cardiovascular pharmacogenomics. Roden DM, Johnson JA, Kimmel SE, Krauss RM, Medina MW, Shuldiner A, Wilke RA (2011) Circ Res 109: 807-20 Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Shimada T, Guengerich FP (1989) Proc Natl Acad Sci U S A 86: 462-5 Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Yang JJ, Cheng C, Devidas M, Cao X, Campana D, Yang W, Fan Y, Neale G, Cox N, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Bowman WP, Camitta B, Reaman GH, Carroll WL, Willman CL, Hunger SP, Evans WE, Pui CH, Loh M, Relling MV (2012) Blood 120: 4197-204 Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Shimada T, Martin MV, Pruess-Schwartz D, Marnett LJ, Guengerich FP (1989) Cancer Res 49: 6304-12 Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR (1996) Cancer Res 56: 2979-84 Selectivity of rat and human glutathione S-transferases in activation of ethylene dibromide by glutathione conjugation and DNA binding and induction of unscheduled DNA synthesis in human hepatocytes. Cmarik JL, Inskeep PB, Meredith MJ, Meyer DJ, Ketterer B, Guengerich FP (1990) Cancer Res 50: 2747-52 Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Atsmon J, Freeman ML, Meredith MJ, Sweetman BJ, Roberts LJ (1990) Cancer Res 50: 1879-85 Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Shimada T, Iwasaki M, Martin MV, Guengerich FP (1989) Cancer Res 49: 3218-28 Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Guengerich FP (1988) Cancer Res 48: 2946-54 Excretion of the mercapturic acid S-[2-(N7-guanyl)ethyl]-N-acetylcysteine in urine following administration of ethylene dibromide to rats. Kim DH, Guengerich FP (1989) Cancer Res 49: 5843-7 Metabolic activation of carcinogens. Guengerich FP (1992) Pharmacol Ther 54: 17-61 Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges. Lockhart JN, Stevens DM, Beezer DB, Kravitz A, Harth E (2015) J Control Release 220: 751-7 Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin. May DG, Black CM, Olsen NJ, Csuka ME, Tanner SB, Bellino L, Porter JA, Wilkinson GR, Branch RA (1990) Clin Pharmacol Ther 48: 286-95 New applications of bacterial systems to problems in toxicology. Guengerich FP, Gillam EM, Shimada T (1996) Crit Rev Toxicol 26: 551-83 The role of factor XI in coagulation. Broze GJ, Gailani D (1993) Thromb Haemost 70: 72-4 Metabolism of chemical carcinogens. Guengerich FP (2000) Carcinogenesis 21: 345-51 Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays. Shimada T, Gillam EM, Sandhu P, Guo Z, Tukey RH, Guengerich FP (1994) Carcinogenesis 15: 2523-9 Metabolic activation of aromatic amines by human pancreas. Anderson KE, Hammons GJ, Kadlubar FF, Potter JD, Kaderlik KR, Ilett KF, Minchin RF, Teitel CH, Chou HC, Martin MV, Guengerich FP, Barone GW, Lang NP, Peterson LA (1997) Carcinogenesis 18: 1085-92 The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines. Yueh MF, Nguyen N, Famourzadeh M, Strassburg CP, Oda Y, Guengerich FP, Tukey RH (2001) Carcinogenesis 22: 943-50 Mechanisms of formation of DNA adducts from ethylene dihalides, vinyl halides, and arylamines. Guengerich FP (1994) Drug Metab Rev 26: 47-66 Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. Parsons WG, Roberts LJ (1988) J Immunol 141: 2413-9 Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. Roberts LJ, Sweetman BJ, Oates JA (1981) J Biol Chem 256: 8384-93 Oxygen radical-dependent epoxidation of (7S,8S)-dihydroxy-7,8-dihydrobenzo[a]pyrene in mouse skin in vivo. Stimulation by phorbol esters and inhibition by antiinflammatory steroids. Ji C, Marnett LJ (1992) J Biol Chem 267: 17842-8 Translesion synthesis across O6-alkylguanine DNA adducts by recombinant human DNA polymerases. Choi JY, Chowdhury G, Zang H, Angel KC, Vu CC, Peterson LA, Guengerich FP (2006) J Biol Chem 281: 38244-56 Efficiency of phosphorylation of the cyclobut-G (A-69992) enantiomers by HSV-1 thymidine kinase does not correlate with their anti-herpesvirus activity. Kohlbrenner WE, Carter CD, Fesik SW, Norbeck DW, Erickson J (1990) Biochem Pharmacol 40: R5-10 Biotransformation of tritiated fentanyl in human liver microsomes. Monitoring metabolism using phenylacetic acid and 2-phenylethanol. Tateishi T, Wood AJ, Guengerich FP, Wood M (1995) Biochem Pharmacol 50: 1921-4 Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state. Fan-Havard P, Liu Z, Chou M, Ling Y, Barrail-Tran A, Haas DW, Taburet AM, ANRS12154 Study Group (2013) Antimicrob Agents Chemother 57: 2154-60 Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Acosta EP, Kendall MA, Gerber JG, Alston-Smith B, Koletar SL, Zolopa AR, Agarwala S, Child M, Bertz R, Hosey L, Haas DW (2007) Antimicrob Agents Chemother 51: 3104-10 Influence of dietary fat type on benzo(a)pyrene [B(a)P] biotransformation in a B(a)P-induced mouse model of colon cancer. Diggs DL, Myers JN, Banks LD, Niaz MS, Hood DB, Roberts LJ, Ramesh A (2013) J Nutr Biochem 24: 2051-63 Purification and characterization of human liver microsomal cytochrome P-450 2A6. Yun CH, Shimada T, Guengerich FP (1991) Mol Pharmacol 40: 679-85 Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Rendic S, Guengerich FP (2010) Curr Drug Metab 11: 4-84 Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in human hepatic microsomes by ipomeanol analogs--an exploratory study. Nunes MG, Desai D, Koehl W, Spratt TE, Guengerich FP, Amin S (1998) Cancer Lett 129: 131-8 Aflatoxin B1 activation in human lung. Kelly JD, Eaton DL, Guengerich FP, Coulombe RA (1997) Toxicol Appl Pharmacol 144: 88-95 Activation and detoxication of aflatoxin B1. Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H, Langouët S (1998) Mutat Res 402: 121-8 Activation of procarcinogens by human cytochrome P450 enzymes. Guengerich FP, Shimada T (1998) Mutat Res 400: 201-13 Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2. Turesky RJ, Guengerich FP, Guillouzo A, Langouët S (2002) Mutat Res 506-507: 187-95 Metabolic activation of carcinogenic 1-nitropyrene by human cytochrome P450 1B1 in Salmonella typhimurium strain expressing an O-acetyltransferase in SOS/umu assay. Hatanaka N, Yamazaki H, Oda Y, Guengerich FP, Nakajima M, Yokoi T (2001) Mutat Res 497: 223-33 Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1. Yamazaki H, Hatanaka N, Kizu R, Hayakawa K, Shimada N, Guengerich FP, Nakajima M, Yokoi T (2000) Mutat Res 472: 129-38
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.